During an over three-hour hearing on the matter relating to oxygen crisis and shortage of medicines to treat COVID-19 patients in the national capital, the court observed that the "problem lies with the Delhi government" and directed nodal officer Udit Prakash to ensure supply of oxygen by cylinders to hospitals and nursing homes "without fail".
As the pandemic spreads and the urgency for effective treatment of COVID-19 mounts, several countries, including the US, have started relying heavily on HCQ, majorly used in the treatment of malaria and rheumatoid-arthritis.
Like pharmaceutical companies globally - which used to enjoy a preferential exchange rate in Venezuela - Indian producers have been left badly stung by the collapse of the bolivar currency
The further distribution of vaccine to the districts will be done as per the registered beneficiaries, for which a separate communication will be done shortly, the letter stated.
Indian auto and pharma industries import several critical components and raw materials from China.
There were apprehensions in the SII about rival Bharat Biotech's 'indigenous' tag, opening up shortcuts for it. One senior person, who was very familiar with the sector, told me, 'The message has gone out from the very top. Somani (V G Somani -- drug controller general of India) has told me "Bharat ka karna hai".' A fascinating excerpt from Abantika Ghosh's Billions Under Lockdown: The Inside Story Of India's Fight Against COVID-19.
"The president pledged America's steadfast ongoing support for the people of India, who have been impacted by the recent surge in the COVID-19 cases," White House Press Secretary Jen Psaki told reporters at her daily news conference.
On her maiden visit to India, US Food and Drug Administrator Margaret A Hamburg has said recent lapses in quality by a handful of pharma companies has overshadowed the good things done by other Indian companies, who emphasise on quality products and practices.
Pharma industry lauds idea, but suggests looser rules on ground
Few drugs in the market are not approved by the authorities and can be life-threatening.
US firm Mylan NV received a stern warning from the FDA in August for faulty manufacturing practices at three of its India drugmaking plants.
At a time when the country's medical infrastructure has become incapable of handling the pressure of Covid's deadly second wave, a parallel wave of conmen, black marketers and counterfeiters can be witnessed across the country. Geetanjali Krishna reports.
Serum Institute already has two deals of 100 million each to supply the Oxford-AstraZeneca and the Novavax vaccine to Gavi-Covax at $3 per dose.
Expectations of Healthcare sector from Union Budget 2013-14.
It is one of 42 drug-making factories in India that the FDA has banned in recent years
In a fresh crackdown on the multi-billion National Rural Health Mission scam, the Central Bureau of Investigation on Friday carried out as many as 30 raids across five different cities in Uttar Pradesh.
Torrent to buy Ranbaxy's anti-bacterial generic
The central government should provide for free vaccination to all Indian citizens and greatly ramp up RT-PCR testing in both rural and urban areas, a group of former civil servants said on Thursday in an open letter to Prime Minister Narendra Modi.
The government is targeting 1,200 technical collaborations between Japanese companies and Indian investors for over Rs 42,000 crore, 200 joint ventures with overseas investors for Rs 14,000 crore, and another Rs 14,000-crore investment from about 50 multinational companies.
The Covishield maker's forte throughout the past half a century has been a combination of affordable vaccines and high volumes. Its tetanus, diphtheria and measles vaccines are known throughout the world, reports Sohini Das.
The US Food and Drug Administration has tightened rules for selling dietary supplements in the US market, making compliance with current good manufacturing practices mandatory for manufacturers.
'If the almost literally heart-stopping Suez block has any positive outcome, it is to be hoped that it will accelerate the setting up of a fab (perhaps Taiwanese) in India,' asserts Rajeev Srinivasan.
The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the United States.
The move assumes significance because a go-ahead from the US Food and Drug Administration for the new unit in Visakhapatnam is likely to give a huge boost to the company's revenues in upcoming quarters.
The ICMR is working on a war footing to develop the testing ecosystem -- especially for the screening blood tests. NIV, Pune, is in the process of validating antibody-based screening kits.
Not to say that India couldn't have handled the situation better, but on average, it didn't do anywhere near as badly as the naysayers make it out argues Rajeev Srinivasan.
As its factories resumed operations after over two-month of grim battle against coronavirus, China is busy tapping into the vast business opportunities of export of key medical goods, specially ventilators and personal protection equipment (PPE), across the world, including India, where both private and government bodies are placing orders for the import of these products.
Prime Minister Narendra Modi also thanked Brazilian President Michel Temer for "understanding India's aspiration" for membership of the Nuclear Suppliers Group.
The new US bio-terrorism law, which mandates prior registration of food suppliers with the USFDA, is likely to adversely affect the Indian food and marines exports, warns a leading non-government organisation EAN-India.
Bulgarian triple jumper Gabriela Petrova had her doping suspension lifted by the IAAF on Monday, less than a week after the World Anti-Doping Agency (WADA) announced an amnesty for athletes who had tested positive for meldonium before March 1.
US markets have been very lucrative for the Indian pharma companies and many companies such as Ranbaxy and Dr Reddy's capitalised on this opportunity.
Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.
Observing that the economic recovery was not yet fully entrenched, the RBI Governor said recovery is likely to be gradual.
The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
His remarks without naming any country came against the backdrop of tension between India and Pakistan after New Delhi revoked Jammu and Kashmir's special status.
The ministry said there should be no interruptions in the services of small retail shops, large organised retail stores and e-commerce companies.
Winning against Covid means thinking ahead, at least six months, putting in place the likely scenarios of what might happen, and then planning. Planning is the role of the government. Having planned, it should communicate what and why. Then, get out of the way, recommends Naushad Forbes.
South-east Asian countries are emerging as preferable destination for India's pharma companies to expand their business as they share similar patient population and disease profile and moreover, have a conducive environment for their operations like easy market approach without any regulatory uncertainty, the survey of Indian pharma firms highlighted.
Sun Pharmaceutical's acquisition of Ranbaxy has received final approvals.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances